Johnson Johnson Aktie WKN: 853260 / ISIN: US4781601046
Symbol: JNJ

130,14EUR
+2,94EUR
+2,31%
17:44:59
155,60USD
+2,58USD
+1,69%
18:17:59
Diese Aktie kaufen
mehr Daten anzeigen
Werbung

Johnson Johnson Aktien News

02.02.21
Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU (EN, Johnson & Johnson)
03.02.21
Johnson & Johnson to Participate in the Raymond James 42nd Annual Institutional Investors Conference (EN, Johnson & Johnson)
03.02.21
REVEAL Lite 2 Risk Calculator Offers Simplified Model to Assess One-Year Mortality Risk Status in Patients with Pulmonary Arterial Hypertension (PAH) (EN, Johnson & Johnson)
04.02.21
Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate (EN, Johnson & Johnson)
05.02.21
Johnson & Johnson to Participate in the Cowen 41st Annual Health Care Virtual Conference (EN, Johnson & Johnson)
08.02.21
SPRAVATO® (Esketamine Nasal Spray) Authorised in Europe for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder (EN, Johnson & Johnson)
08.02.21
Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination (EN, Johnson & Johnson)
08.02.21
Janssen Announces Treatment with ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer (EN, Johnson & Johnson)
16.02.21
Johnson & Johnson Announces Submission of European Conditional Marketing Authorisation Application to the EMA for its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate (EN, Johnson & Johnson)
19.02.21
Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate (EN, Johnson & Johnson)
26.02.21
Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee (EN, Johnson & Johnson)
28.02.21
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use (EN, Johnson & Johnson)
28.02.21
Johnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S. (EN, Johnson & Johnson)
01.03.21
Cardinals agree to terms with free agent edge rusher JJ Watt (EN, Chinapost)
02.03.21
Johnson & Johnson Statement on Collaboration with Merck (EN, Johnson & Johnson)
16:24 Uhr
Johnson & Johnson COVID-19 Vaccine Granted Authorization under Interim Order by Health Canada For Emergency Use (EN, Johnson & Johnson)

Johnson Johnson News

Johnson Johnson News: auf dieser Seite finden Sie alle Johnson Johnson News und Nachrichten zur Johnson Johnson Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Johnson Johnson News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Johnson Johnson News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln